Sai Healthcare Consulting Interview Questions and Answers

Assessing new product introduction for cleaning validation involves evaluating the cleaning process, potential residues, and ensuring compliance with regulatory requirements.

• Evaluate the cleaning process to ensure it effectively removes any residues from the new product.

• Identify potential residues that may be left behind and determine the appropriate cleaning methods to address them.

• Ensure that the cleaning validation process complies with regulatory requirements, such as FDA...read more

ICH guidelines recommend conducting risk assessment to identify, evaluate, and prioritize potential risks in pharmaceutical development.

• ICH guidelines emphasize the importance of risk assessment in pharmaceutical development

• Risk assessment involves identifying, evaluating, and prioritizing potential risks

• It helps in determining the likelihood and impact of risks on the quality, safety, and efficacy of pharmaceutical products

• Examples of risks include contamination, formulation...read more

Critical process parameters for wet granulation include binder type, binder concentration, granulation liquid amount, mixing time, and drying temperature.

• Binder type: Determines the binding strength of the granules.

• Binder concentration: Affects the granule size and strength.

• Granulation liquid amount: Influences the wet massing and granule formation.

• Mixing time: Determines the uniformity of the granule size.

• Drying temperature: Impacts the final granule properties.

Disintegration time varies for different types of tablets depending on their composition and formulation.

• Disintegration time is the time taken for a tablet to break down into smaller particles in the presence of water or other fluids.

• Tablets can be classified as immediate-release, extended-release, or delayed-release based on their disintegration time.

• Immediate-release tablets typically disintegrate within 30 minutes, while extended-release tablets can take several hours to d...read more

I can cover up to 80% of ARRA.

• I have extensive experience in the region and have built strong relationships with key stakeholders.

• I have a proven track record of exceeding sales targets and driving revenue growth.

• I am confident in my ability to effectively communicate the value proposition of our products and services to potential customers.

• I am committed to staying up-to-date on industry trends and best practices to ensure continued success.

• For example, in my previous role a...read more

Perimeters of tablets refer to the physical dimensions and characteristics of the tablet.

• Perimeters include size, shape, thickness, and weight of the tablet.

• Tablets can come in various shapes such as round, oval, or rectangular.

• The thickness of a tablet can vary depending on the dosage and formulation.

• Weight of a tablet is important for dosing accuracy and patient compliance.

I have extensive experience in OSD manufacturing and process development.

• Developed and optimized OSD formulations for various drug products

• Implemented process improvements to increase efficiency and reduce costs

• Managed OSD manufacturing operations and ensured compliance with regulatory requirements

• Collaborated with cross-functional teams to troubleshoot and resolve technical issues

• Trained and mentored junior staff on OSD manufacturing and development

• Implemented quality contro...read more